Information about open clinical trials in Infectious Diseases at the University of Kentucky Chandler Medical Center and eligibility criteria will be posted here as they are approved by the University of Kentucky Medical Institutional Review Board.

Project Title: A Phase II, Open-label, multicenter study to Evaluate the Safety, Tolerability and Biological Activity of Repeated Doses of Autologous T Cells Transduced with VRX496 in HIV + patients.
Sponsor: VIRxSYS Corporation, Inc.
Status: open to enrollment
Contact: Dr. Greenberg @ 859-323-6327 or Heather Vaughn @ 859-323-3933

Project Title: "IMPACT" Phase IV, multicenter, cross-sectional study to evaluate the I50L substitution among subjects experiencing virologic failure on a HAART regimen containing Atazanavir
Sponsor: Bristol Myers Squibb
Status: open to enrollment
Contact: Dr. Greenberg @ 859-323-6327 or Heather Vaughn @ 859-323-3933

Project Title: Vaccine trials for Smallpox Vaccines (3 different protcols) and Anthrax vaccine-- Ages 18 and older
Sponsor:  Acambis (Smallpox vaccines) and Vaxgen (Anthrax vaccine)
Status: Closed to enrollment
Contact: Debbie at 859-257-5467

Other questions about the Clinical Trials can be directed to Dr. Richard Greenberg 859-323-6327.